ORAL PRESENTATIONS
Session 1: Innovations in Treatment, Vaccines and Cure
Marlou Jongkees
Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people living with HIV with hyporesponse after primary vaccination
Download Presentation
José Dekker
HIV-1 3’-polypurine tract mutations confer dolutegravir resistance by switching to an integration-independent replication mechanism via 1-LTR circles
Download Presentation
Henrieke Prins
The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy.
Download Presentation
Session 2: Barriers to Testing, Removing the HIV Reservoir, and Reducing Transmission
Hanneke Goense
Evaluating the implementation of home-based sexual health care among men who have sex with men using the RE-AIM framework
Download Presentation
Carlijn Jordans
HIV teams as a tool to improve HIV indicator condition-guided testing: the necessity of being aware
Download Presentation
Ye Liu
CRISPR-Cas attack on the HIV-1 provirus can cause unintended deletion of surrounding cellular DNA
Download Presentation
Marieke Nühn
Detection of Intact HIV proviral DNA in the CNS of a virally suppressed HIV-infected individual
Download Presentation
Marije Hofstra
Transmission of (drug resistant) HIV between the Dutch Caribbean islands and the Netherlands
Download Presentation
Session 3: Weighing in on cis- and transgender women, talking sex and eliminating HIV and HCV
Suzanne de Munnik
Development of a sexual health-counselling program for HIV care providers during routine consultations; an Intervention Mapping approach.
Download Presentation
Elske Hoornenborg
Assessing the HIV care continuum among transgender women between 2010 and 2020 in the Netherlands: does HIV care engagement differ from that of men who have sex with men?
Download Presentation
Daniela van Santen
Progress towards WHO HCV elimination incidence targets among people with HIV: findings from the International Collaboration on Hepatitis C Elimination in HIV Cohorts
Download Presentation
POSTER PRESENTATIONS
Theme: ART and other clinical topics
Marta Vasylyev
Dolutegravir/lamivudine is clinically non-inferior to dolutegravir based triple drug antiretroviral therapy: 1 year results of the DUALING prospective matched real-world cohort study.
Download Presentation
Vincent Lanting
One year of follow-up after switching to doravirine in treatment experienced HIV-patients.
Download Presentation
Marc Blaauw
Prevalence of Traditional cardiovascular risk factors and guideline adherence in prevention of cardiovascular disease in people living with HIV in the Netherlands.
Download Presentation
Lisanne Bevers
First pharmacokinetic data of dolutegravir in combination with a TAF containing backbone in children living with HIV.
Download Presentation
Marjolein Poen
The vision of people living with HIV on current and future HIV care in the Netherlands
Download Presentation
Carlijn Jordans
Digital emergency healthcare consultation behavior of Ukrainians living with HIV in Europe.
Download Presentation
Patrick Oomen
Impact of past Pneumocystis Jirovecii pneumonia on diffusion capacity in people living with HIV: a drop in the ocean
Download Presentation
Theme: Cure, remission and vaccines
Franco Romero Gonzalez
Impact of HIV post-treatment control and elimination on the HIV epidemic among men who have sex with men in the Netherlands
Download Presentation
Angela Schriek
Fc-engineering of anti-HIV-1 antibodies and nanobodies to improve Fc mediated effector functions
Download Presentation
Ninée Buchholtz
Distinct detection of intact and defective proviral DNA for HIV subtype B and C
Download Presentation
Stefanie Kroeze
Abortive HIV-1 RNA transcripts are detected in serum of people living with HIV during long-term effective antiretroviral therapy.
Download Presentation
Killian Vlaming
Co-stimulation of TLR-8 and Rig-I-like Receptors to eliminate re-activated HIV-1 reservoirs by enhancing antiviral immune responses.
Download Presentation
Pien van Paassen
A longitudinally enhanced CD8+ T cell response accounts for 22 years post-treatment control in an HLA-B*44 positive patient temporarily treated during HIV infection
Download Presentation
Lisa van Pul
A genetic variation in Fucosyltransferase 8 accelerates HIV-1 disease progression indicating a role for N-glycan fucosylation
Download Presentation
Kim Romijnders
The expected impact of an HIV cure on the quality of life, stigma and sexual satisfaction of people living with HIV and key populations vulnerable to HIV in the Netherlands
Download Presentation
Theme: Monkeypox & HIV
Haoyi Wang
Lower perceived concern for PrEP users, higher perceived risk for MSM with HIV: Perceived concern and risk of getting infected with monkeypox among MSM living in the Netherlands, July 2022.
Download Presentation
Nicole Dukers
Monkeypox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in The Netherlands (Dutch MPX-survey)
Download Presentation
Hanne Zimmermann
Comparing beliefs driving stigma across commonly stigmatized infections among MSM: the case of monkeypox, HIV, syphilis, chlamydia, and gonorrhoea
Download Presentation
Theme: Transmission, testing, behavior, PrEP
Kris Hage
Behavioural risk before, during and after hepatitis C treatment among men who have sex with men with HIV before and in the direct-acting antiviral era
Download Presentation
Carlijn Jordans
Improving the HIV testing cascade: implementing HIV teams to support HIV indicator condition-guided testing in general practice in the Netherlands.
Download Presentation
Feline De la Court
Characterizing subgroups of sexual behaviors among men who have sex with men eligible for, but not using, PrEP in the Netherlands
Download Presentation
Eline Wijstma
Sexual behavior and STT incidence during the first four years of PREP use amonf MSM.
Download Presentation
Jeffrey Koole
Intention to use long-acting HIV PrEP among key populations, the Netherlands, 2022
Download Presentation
Alexandra Blenkinsop
Shifting sources of HIV infections among Amsterdam residents: further findings from the ROADMAP study, 2010-2021
Download Presentation
Saskia Bogers
Mapping hematologists’ HIV testing behavior among lymphoma patients in Amsterdam, the Netherlands – A mixed-methods study
Download Presentation
Hanne Zimmermann
Do cross-border differences in HIV-testing determine the first pillar of the care continuum? Data from a EuRegional setting bridging Belgium, Germany, and The Netherlands
Download Presentation
Oladipupo Shobowale
HIV Testing and Linkage to Care in Sub-Saharan African Migrants in the Netherlands
Download Presentation